8-K 1 form8ksas.htm FORM 8K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 20, 2005

PSS WORLD MEDICAL, INC.

(Exact name of Registrant as specified in its charter)

Commission File Number: 0-23832

Florida

59-2280364

(State or other jurisdiction

(IRS Employer

of incorporation or organization)

Identification Number)

 

 

4345 Southpoint Blvd.

 

Jacksonville, Florida

32216

(Address of principal executive offices)

(Zip code)

 

 

 

 

Registrant’s telephone number, including area code

(904) 332-3000

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 

 

Item 8.01.

Other Events.

PSS World Medical, Inc. (the “Company”) entered into a Stock Purchase Agreement, dated as of September 20, 2005, with R. Mike Stamps, M. Todd Stamps, and G. Patrick Stamps, the shareholders of Southern Anesthesia & Surgical, Inc. (“SAS”), pursuant to which the Company has agreed to acquire all of the outstanding common stock of SAS. The press release is attached as Exhibit 99.1 to this report and is incorporated herein by reference.

Item 9.01.

Financial Statements and Exhibits.

 

(a)

Not Applicable.

 

 

(b)

Not Applicable.

 

 

(c)

Exhibits:

 

 

Exhibit Number

 

Description

 

 

 

 

99.1

Press Release dated September 21, 2005.

 

 

 

 

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: September 22, 2005

PSS WORLD MEDICAL, INC.

 

By: /s/ David M. Bronson_______________

 

Name:

David M. Bronson

 

  Title:

  Executive Vice President and Chief Financial Officer

 

 

 

 

 

 

EXHIBIT INDEX

 

 

99.1

Press Release dated September 21, 2005.